ArticleAnalytical chemistry2025
Protein Recognition of Glycosphingolipids in Membranes: Mechanistic and Quantitative Insights.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The bioactive sphingolipid playbook. A primer for the uninitiated as well as sphingolipidologists.Journal of lipid research · 2025Review
- Quantifying Protein-Glycan Interactions Using Native Mass Spectrometry.Mass spectrometry reviewsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Recognition of glycosphingolipids (GSLs) in cell membranes by glycan-binding proteins (GBPs) is essential for diverse biological processes. However, owing to deficiencies in available analytical methods, the thermodynamics of GBP-GSL interactions remains poorly characterized. Native mass spectrometry (nMS) analysis performed using soluble GSL-containing model membranes provides a direct readout of the identity and stoichiometry of bound GSL ligands and, under certain conditions, can inform on affinity. Yet, for multivalent GBPs capable of engaging multiple model membranes simultaneously, data analysis relies on untested assumptions, which has limited adoption of the assay. Here, we apply mass photometry to quantify a series of high-affinity interactions between glycolipids in soluble model membranes (nanodiscs) and mono- and multivalent GBPs and compare with binding data acquired with nMS. Remarkably, the mass photometry results indicate that glycolipids are distributed nonstatistically across the lipid bilayer and engage in clustering that is sensitive to GBP binding. Moreover, the affinities and stoichiometries (of bound nanodiscs) measured for multivalent GBPs are strongly modulated by glycolipid clustering, which can overwhelm avidity gains from multivalent binding. After normalization for the number of GBP binding sites and glycolipid content, the affinities from mass photometry are found to be, overall, in good agreement with native nMS-derived affinities. Collectively, the findings of this study provide critically needed affinity and stoichiometry benchmarks for assay validation and significant new insights into the mechanisms of GBP recognition of GSLs in model membranes, which serve as a foundation for understanding binding in natural cellular environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.